Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza 2021-09-08 20:30
The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare 2021-09-08 19:00
Gannex Announces Positive Topline Results from the U.S. Phase I Trial of Drug-Drug Interactions in Healthy Subjects and Pharmacokinetics in Patients with NAFLD for Its THRβ Agonist ASC41 2021-09-08 08:30
Innovent Announces First Patient with Type 2 Diabetes Dosed in a Phase 2 Clinical Trial of IBI362 (a GLP-1R and Glucagon Receptor Dual Agonist) in China 2021-09-08 08:00
Stem Cells for Everyone: I Peace expands its clinical-grade iPSC banking service leveraging mass manufacturing capability 2021-09-08 02:00
Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration 2021-09-07 20:00
RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis 2021-09-07 19:00
RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021 2021-09-07 18:00
Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer 2021-09-07 16:11
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease 2021-09-07 12:00
Laureates of the 2021 Global Energy Prize Announced 2021-09-06 20:00
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant 2021-09-06 13:44
GeneQuantum and BrighGene sign agreement for development of antibody immune agonist conjugates 2021-09-06 09:00
AffaMed Therapeutics Enters into Strategic Partnership Agreement with Beijing Tiantan Hospital and Infinite Brain Technologies to Promote Digital Therapy in Neurological Diseases 2021-09-06 08:00
WuXi AppTec Receives AA ESG Rating from MSCI 2021-09-06 08:00
The National Medical Products Administration (NMPA) issues product license for Abiraterone acetate 250 mg, Bioequivalance study conducted in India by Accutest Research Laboratories (I) Pvt. Ltd., one of the Top Indian CRO 2021-09-06 08:00
Avidity Science Announces Agreement to Divest Lab Products & Harford Systems 2021-09-04 00:00
PharmAbcine Receives HREC Clearance for Phase II Trial of Olinvacimab and Pembrolizumab in mTNBC 2021-09-03 20:00
Arctic Vision Obtains China IND Clearance for Phase III Study of ARVN003, the First in China for Presbyopia Treatment 2021-09-03 08:00
Clinical trial provides preliminary evidence of a cure for myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and Long Covid 2021-09-03 06:00
1 224 225 226 227 228 453